Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.
Saved in:
| Title: | Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers. |
|---|---|
| Authors: | Belinger L; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland. Electronic address: lydia.belinger@bil.uzh.ch., Rieser NM; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Engeli EJE; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Becciolini L; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Clamote M; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Pribis M; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Saissi F; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Florineth GA; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; Graduate School for Health Sciences, University of Bern, Bern, Switzerland., Hehl NL; Department of Child and Adolescent Psychiatry, Psychiatric University Clinic Zurich and University of Zurich, Zurich, Switzerland., Herdener M; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland., Preller KH; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland. |
| Source: | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2026 May 28; Vol. 111, pp. 112879. Date of Electronic Publication: 2026 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42208423 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Belinger+L%22">Belinger L</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland. Electronic address: lydia.belinger@bil.uzh.ch.<br /><searchLink fieldCode="AU" term="%22Rieser+NM%22">Rieser NM</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Engeli+EJE%22">Engeli EJE</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Becciolini+L%22">Becciolini L</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Clamote+M%22">Clamote M</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pribis+M%22">Pribis M</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Saissi+F%22">Saissi F</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Florineth+GA%22">Florineth GA</searchLink>; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland; Graduate School for Health Sciences, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hehl+NL%22">Hehl NL</searchLink>; Department of Child and Adolescent Psychiatry, Psychiatric University Clinic Zurich and University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Herdener+M%22">Herdener M</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Preller+KH%22">Preller KH</searchLink>; Department of Adult Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229111390%22">European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology</searchLink> [Eur Neuropsychopharmacol] 2026 May 28; Vol. 111, pp. 112879. <i>Date of Electronic Publication: </i>2026 May 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9111390 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-7862 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220924977X%22">0924977X </searchLink><i>NLM ISO Abbreviation: </i>Eur Neuropsychopharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42208423 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.euroneuro.2026.112879 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 112879 Titles: – TitleFull: Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Belinger L – PersonEntity: Name: NameFull: Rieser NM – PersonEntity: Name: NameFull: Engeli EJE – PersonEntity: Name: NameFull: Becciolini L – PersonEntity: Name: NameFull: Clamote M – PersonEntity: Name: NameFull: Pribis M – PersonEntity: Name: NameFull: Saissi F – PersonEntity: Name: NameFull: Florineth GA – PersonEntity: Name: NameFull: Hehl NL – PersonEntity: Name: NameFull: Herdener M – PersonEntity: Name: NameFull: Preller KH IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 05 Text: 2026 May 28 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-7862 Numbering: – Type: volume Value: 111 Titles: – TitleFull: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology Type: main |
| ResultId | 1 |
